|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 7/20/17 Syros Pharmaceuticals, Inc. S-3 9:1.9M Merrill Corp-MD/FA |
Document/Exhibit Description Pages Size
1: S-3 Registration Statement for Securities Offered HTML 373K
Pursuant to a Transaction
2: EX-1.2 Underwriting Agreement HTML 182K
3: EX-4.1 Instrument Defining the Rights of Security Holders HTML 319K
4: EX-4.2 Instrument Defining the Rights of Security Holders HTML 345K
5: EX-4.3 Instrument Defining the Rights of Security Holders HTML 49K
6: EX-4.4 Instrument Defining the Rights of Security Holders HTML 49K
7: EX-5.1 Opinion re: Legality HTML 33K
8: EX-12.1 Statement re: Computation of Ratios HTML 34K
9: EX-23.1 Consent of Experts or Counsel HTML 7K
Exhibit 12.1
COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
(dollars in thousands)
|
|
|
Three Months |
|
Year Ended December 31, |
| |||||||||||
|
|
|
|
2016 |
|
2015 |
|
2014 |
|
2013 |
| ||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
|
Fixed charges: |
|
|
|
|
|
|
|
|
|
|
| |||||
|
Interest expense on indebtedness |
|
$ |
3 |
|
$ |
19 |
|
$ |
18 |
|
$ |
— |
|
$ |
33 |
|
|
Interest expense on portion of rent expense representative of interest |
|
301 |
|
1,187 |
|
364 |
|
241 |
|
244 |
| |||||
|
Total fixed charges |
|
$ |
304 |
|
$ |
1,206 |
|
$ |
382 |
|
$ |
241 |
|
$ |
277 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
|
Net loss |
|
$ |
(11,515 |
) |
$ |
(47,743 |
) |
$ |
(29,818 |
) |
$ |
(13,431 |
) |
$ |
(8,665 |
) |
|
Fixed charges per above |
|
304 |
|
1,206 |
|
382 |
|
241 |
|
277 |
| |||||
|
Total earnings (loss) |
|
$ |
(11,211 |
) |
$ |
(46,537 |
) |
$ |
(29,436 |
) |
$ |
(13,190 |
) |
$ |
(8,388 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
|
Ratio of earnings to fixed charges |
|
N/A |
|
N/A |
|
N/A |
|
N/A |
|
N/A |
| |||||
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
|
Deficiency of earnings available to cover fixed charges |
|
$ |
(11,515 |
) |
$ |
(47,743 |
) |
$ |
(29,818 |
) |
$ |
(13,431 |
) |
$ |
(8,665 |
) |
| This ‘S-3’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| 12/31/17 | ||||
| Filed on: | 7/20/17 | 8-A12B/A | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/27/17 SEC UPLOAD¶ 10/27/17 1:131K Syros Pharmaceuticals, Inc. |